April 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
According to market projections, the companion diagnostic technologies sector is expected to grow from USD 3.10 billion in 2024 to USD 9.06 billion by 2034, reflecting a CAGR of 11.34%. The increasing demand for personalized medicines, rising incidences of cancer and other chronic disorders, and technological advancements drive the market....
April 21, 2026
Diabetes affects millions worldwide, with over 422 million people impacted. The rise in diabetes, especially Type 2, is driving demand for devices like diabetic lancets, which help monitor blood glucose levels. With a growing elderly population and increasing awareness, the market for these devices is expanding globally....
April 21, 2026
Cord blood, collected from the umbilical cord after birth, contains stem cells that treat various disorders. Cord blood banks offer storage options for family-only access (private banks) or public use. Rising cases of cancers and genetic disorders drive demand, alongside new initiatives enhancing storage and treatment access....
April 21, 2026
Bioinformatics leverages computational tools to analyze and interpret biological data, aiding in gene expression, protein regulation, and molecular biology evolution. Advances in genomics, drug discovery, and government support for omics research are driving market growth. Recent innovations include WHO’s 2024 workshop on genomic surveillance...
April 21, 2026
According to market projections, the compounding pharmacy sector is expected to grow from USD 13.86 billion in 2024 to USD 22.91 billion by 2034, reflecting a CAGR of 5.15%, tailoring medications for unique patient needs, such as dye allergies or non-pill forms. Valor Compounding Pharmacy and Revelation Pharma recently expanded through partnerships...
April 21, 2026
Androgenetic alopecia, a genetic condition causing gradual hair loss, affects up to 50% of men and women, with Caucasians showing the highest prevalence. In 2024, Pelage Pharmaceuticals raised $16.75M for hair loss therapies, while a company raised $4M to treat this genetic condition....
April 21, 2026
The immunodiagnostics market is growing with innovations like ELISA, CLIA, and fluorescent immunoassays. The National Institute of Biologicals and regulatory bodies oversee quality and safety for diagnostics, while companies like Thermo Fisher and Serum Institute advance solutions for disease detection and research....
April 21, 2026
DNA diagnostics involve testing genes or chromosomes to detect genetic conditions or predict disease risks. It's used in healthcare, research, biotechnology, and forensics for purposes like newborn screening, genetic counseling, and personalized treatments. Market growth is driven by rising genetic disorders and personalized medicine....
April 21, 2026
The insulin delivery system market is expanding rapidly as diabetes rates rise due to lifestyle and population trends. Key players aim to provide affordable, user-friendly solutions. Notable developments include FDA approvals for innovative devices and AI-driven technologies that enhance personalized care....
April 21, 2026
The C-reactive protein (CRP) test measures inflammation levels in the body, aiding in diagnosing conditions like infections, autoimmune disorders, and heart disease risk. Demand is growing due to aging populations and advanced technologies. Innovations include rapid, sensitive point-of-care CRP tests....